NCT02245542View on ClinicalTrials.gov

The Impact of Alna® Ocas® on Nocturia in Patients With Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia (LUTS/BPH)

CompletedOBSERVATIONAL
Enrollment

5,775

Participants

Timeline

Start Date

April 30, 2005

Primary Completion Date

February 28, 2006

Conditions
Prostatic Hyperplasia
Interventions
DRUG

ALNA®OCAS®

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY